Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 12.71
-0.32 (-2.46%)
At close: Jan 22, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.89 billion as of January 23, 2026. Its market cap has decreased by -32.07% in one year.
Market Cap
2.89B
Enterprise Value
3.38B
Revenue
1.49B
Ranking
n/a
PE Ratio
16.39
Stock Price
12.71
Market Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.89B, an increase of 4,577.49%. That is a compound annual growth rate of 17.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 2.89B | -11.12% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medico Remedies | 4.08B |
| Everest Organics | 3.92B |
| Albert David | 3.91B |
| Amanta Healthcare | 3.58B |
| ZIM Laboratories | 3.45B |
| Trident Lifeline | 3.44B |
| Kerala Ayurveda | 3.39B |
| BDH Industries | 2.28B |